PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR‐TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND... von Kulasekararaj, Austin, Mellor, Jennifer, Earl, Lucy, Wang, Alice, Patel, Yogesh, Myren, Karl‐Johan, Fuereder, Wolfgang, Nagalla, Srikanth

Volltext

Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria von Füreder, Wolfgang, Valent, Peter

Volltext

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study von Lee, Jong Wook, Sicre de Fontbrune, Flore, Wong Lee Lee, Lily, Pessoa, Viviani, Gualandro, Sandra, Füreder, Wolfgang, Ptushkin, Vadim, Rottinghaus, Scott T., Volles, Lori, Shafner, Lori, Aguzzi, Rasha, Pradhan, Rajendra, Schrezenmeier, Hubert, Hill, Anita

Volltext

Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH) von Füreder, Wolfgang, Thalhammer, Renate, Valent, Peter

Volltext

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report von Fuereder, Wolfgang, Valent, Peter

Volltext

Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases von Riedl, Julia, Pfeilstöcker, Michael, Farr, Alex, Häusler, Günther, Ay, Cihan, Füreder, Wolfgang

Volltext

Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML von Valent, Peter, Hadzijusufovic, Emir, Hoermann, Gregor, Füreder, Wolfgang, Schernthaner, Gerit-Holger, Sperr, Wolfgang R., Kirchmair, Rudolf, Wolf, Dominik

Volltext

Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts von Valent, Peter, Büsche, Guntram, Theurl, Igor, Uras, Iris Z, Germing, Ulrich, Stauder, Reinhard, Sotlar, Karl, Füreder, Wolfgang, Bettelheim, Peter, Pfeilstöcker, Michael, Oberbauer, Rainer, Sperr, Wolfgang R, Geissler, Klaus, Schwaller, Jürg, Moriggl, Richard, Béné, Marie C, Jäger, Ulrich, Horny, Hans-Peter, Hermine, Olivier

Volltext

Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up von Yenerel, Mustafa N., Sicre de Fontbrune, Flore, Piatek, Caroline, Sahin, Fahri, Füreder, Wolfgang, Ortiz, Stephan, Ogawa, Masayo, Ozol-Godfrey, Ayca, Sierra, J. Rafael, Szer, Jeff

Volltext

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies von Griffin, Morag, Langemeijer, Saskia, Kulagin, Alexander, Ogawa, Masayo, Yu, Ji, Peffault de Latour, Régis, Latypova, Aigul, Barcellini, Wilma, Barraco, Fiorenza, Beam, Donald, Bettelheim, Peter, Brodsky, Andres, Carnley, Benedict, Cermak, Jaroslav, Chen, Tsai‐Yun, Chew, Lee Ping, Choi, Chul Won, De Guibert, Sophie, Devos, Timothy, Dunaev, Yuri, Dwilewicz‐Trojaczek, Jadwiga, Edahiro, Yoko, Elykomov, Iliya, Engelberger, Maria Ines, Pomponi, Fabrizio, Fuereder, Wolfgang, Fujii, Nobuharu, Fujiwara, Shinichiro, Girault, Stéphane, Gomez Almaguer, David, Gritsaev, Sergey, Hantaweepant, Chattree, Harada, Hiroshi, Höglund, Martin, Husin, Azlan, Ikezoe, Takayuki, Ishiyama, Ken, Jang, Jun Ho, Jo, Deog‐Yeon, Kang, Ka‐Won, Kennedy, James, Kim, Hyo Jung, Kim, Jeong‐A, Kim, Jin Seok, Kimura, Fumihiko, Kosugi, Hiroshi, Kulagin, Alexander, Kulasekararaj, Austin, Lai, Kuan‐Ming, Lee, Gyeong‐Won, Lee, Jae Hoon, Lee, Je‐Hwan, Lee, Jong Wook, Lin, Chien‐Chin, Martynova, Elena, Matsumura, Itaru, Meike, Galina, Menosi Gualandro, Sandra Fátima, Mori, Yasuo, Morita, Kimio, Morselli Ramalho, Fernanda Maria, Muus, Petra, Myasnikov, Alexander, Naito, Kensuke, Ninomiya, Haruhiko, Notaro, Rosario, Okada, Masaya, Okamoto, Shinichiro, Olkhovik, Tatiana, Paquette, Ronald, Park, Joon Seong, Peffault de la Tour, Régis, Piatek, Caroline, Piekarska, Agnieszka, Pospelova, Tatiana, Rojnuckarin, Ponlapat, Rosa Pessoa, Viviani de Lourdes, Rossi, Blanca, Salvino de Araujo, Marco Aurelio, Samuel, Desmond, Shatokhin, Yury, Shelekhova, Tatiana, Sohn, Sang Kyun, Sunami, Kazutaka, Syed Abdul Kadir, Sharifah Shahnaz, Toh, See Guan, Tomita, Akihiro, Torregrosa Diaz, José Miguel, Ueda, Yasutaka, Usuki, Kensuke, Viboonjuntra, Pongtep, Viigimaa, Iige, Volkova, Svetlana, Won, Jong‐Ho, Wong, Lily Lee Lee, Wong, Voon Fei, Yap, Eng Soo, Yeh, Su‐Peng, Yhim, Ho‐Young, Zhuravkov, Andrey

Volltext

Switching From High‐Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report von Füreder, Wolfgang, Valent, Peter

Volltext

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network von Füreder, Wolfgang, Sperr, W. R., Heibl, S., Zebisch, A., Pfeilstöcker, M., Stefanzl, G., Jäger, E., Greiner, G., Schwarzinger, I., Kundi, M., Keil, F., Hoermann, G., Bettelheim, P., Valent, P.

Volltext

Major response of PNH to an AML chemotherapy protocol von Füreder, Wolfgang, Sperr, Wolfgang R., Gleixner, Karoline, Thalhammer, Renate, Schwarzinger, Ilse, Hoermann, Gregor, Kornauth, Christoph, Grünberger, Birgit, Valent, Peter

Volltext

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm von Füreder, Wolfgang, Cerny-Reiterer, Sabine, Sperr, Wolfgang R., Müllauer, Leonhard, Jäger, Eva, Schwarzinger, Ilse, Geissler, Klaus, Valent, Peter

Volltext

Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation... von Füreder, Wolfgang, Paulitsch-Buckingham, Andrea, Rabitsch, Werner, Jäger, Eva, Schwarzinger, Ilse, Sperr, Wolfgang R., Valent, Peter

Volltext

Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria von Alahmad, Adnan, Preuss, Klaus‐Dieter, Schenk, Joachim, Füreder, Wolfgang, Schrezenmeier, Hubert, Müller‐Lantzsch, Nikolaus, Schubert, Jörg, Pfreundschuh, Michael

Volltext

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics von Wacheck, Volker, Lahn, Michael, Dickinson, Gemma, Füreder, Wolfgang, Meyer, Renata, Herndlhofer, Susanne, Füreder, Thorsten, Dorfner, Georg, Pillay, Sada, André, Valérie, Burkholder, Timothy P, Akunda, Jacqueline K, Flye-Blakemore, Leann, Van Bockstaele, Dirk, Schlenk, Richard F, Sperr, Wolfgang R, Valent, Peter

Volltext

Diagnose und Therapie der erworbenen Aplastischen Anämie von Füreder, Wolfgang

Volltext

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron von Mair, Maximilian J., Mitterer, Manfred, Gattinger, Pia, Berger, Julia M., Trutschnig, Wolfgang, Bathke, Arne C., Gansterer, Margaretha, Berghoff, Anna S., Laengle, Severin, Gottmann, Lynn, Buratti, Thomas, Haslacher, Helmuth, Lamm, Wolfgang W., Raderer, Markus, Tobudic, Selma, Fuereder, Thorsten, Valenta, Rudolf, Fong, Dominic, Preusser, Matthias

Volltext

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study von Mair, Maximilian J., Berger, Julia M., Mitterer, Manfred, Gansterer, Margaretha, Bathke, Arne C., Trutschnig, Wolfgang, Berghoff, Anna S., Perkmann, Thomas, Haslacher, Helmuth, Lamm, Wolfgang W., Raderer, Markus, Tobudic, Selma, Fuereder, Thorsten, Buratti, Thomas, Fong, Dominic, Preusser, Matthias

Volltext